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tivecommons.org/licenses/by-nc-Summary Objective: This study aims to establish a noninvasive scoring system to predict the
risk of erosive esophagitis (EE).
Methods: From 2002 to 2009, a total of 34,346 consecutive adults who underwent health
check-ups and upper gastrointestinal endoscopy were retrospectively enrolled. Of the partic-
ipants, 22,892 in the earlier two-thirds period of examination were defined as the training set
and the remaining 11,454 as the validation set. EE was diagnosed by upper gastrointestinal
endoscopy. Independent risk factors associated with EE were analyzed by multivariate analysis
using a logistic regression model with the forward stepwise selection procedure in the training
set. Subsequently, an EE risk scoring system was established and weighted by b coefficient.
This risk scoring system was further validated in the validation set.
Results: In the training set, older age, male gender, higher body mass index, higher waist
circumference, higher serum triglyceride, and lower high-density lipid cholesterol levels were
independent risk factors for predicting EE. According to the b coefficient value of each inde-
pendent risk factor, the total score ranging from 0 to 10 was established, and then low- (0e3),
moderate- (4e6), and high-risk (7e10) groups were identified. In the validation set, theGastroenterology, Department of Medicine, Taipei Veterans General Hospital, Number 201 Shih-Pai
.
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96 H.-H. Hung et al.prevalence rates of EE in the low-, moderate-, and high-risk groups were 5.15%, 15.76% and
26.11%, respectively (p < 0.001).
Conclusion: This simple noninvasive risk scoring system, including factors of age, gender, body
mass index, waist circumference, triglyceride, and high-density lipid cholesterol, effectively
predicted EE and stratified its incidence.
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The incidence of gastroesophageal reflux esophagitis
(GERD) is increasing worldwide [1,2]. The symptoms of
GERD include heart burn, regurgitation, and abdominal pain
with a decreased quality of life [3], which result in a
growing burden for health care systems and employers [1].
Moreover, it may develop serious complications such as
esophageal adenocarcinoma [1]. Consequently, GERD has
become an important health care challenge.
The risk factors of GERD are not fully identified till now.
Recent studies demonstrate that GERD and erosive esoph-
agitis (EE) are associated with metabolic syndromes,
including central obesity and increased waist circumfer-
ence (WC) [4,5]. Moreover, lipid profiles of the metabolic
syndromes have also been demonstrated as independent
risk factors for GERD [4]. Some studies have proposed that
the increasing trend of GERD in the recent decades may be
partly explained by an increasing body mass index (BMI) of
the general population and a higher prevalence of meta-
bolic syndrome worldwide [6,7]. Besides metabolic syn-
dromes, whether other epidemiologic risk factors are
associated with GERD and EE is still under debate [2,8]. For
example, the impact of age and sex on GERD has been
shown to be different between Japan and Western coun-
tries [9].
It is crucial to identify the risk factors for predicting
GERD and EE, which may be benefit for disease control, and
for the target of lifestyle modification and medical thera-
pies. The aim of the present study, therefore, was to
investigate the risk factors for EE and establish a noninva-
sive scoring system to predict its incidence.Materials and methods
Patients
Patients who completed the health check-up service at the
Health Management Center of Taipei Veterans General
Hospital, Taipei, Taiwan from 2002 to 2009 were considered
for enrollment. As gastric cancer is an important cause of
cancer mortality in Taiwan, esophagogastroduodenoscopy
(EGD) is a routine examination in our physical check-up
service. The demographic data including age, sex, BMI, WC,
and blood pressure (BP) were recorded. Patients who did
not have the data of EGD and all the parameters for the
study during health check-up were excluded. Finally,34,346 consecutive and eligible patients were enrolled for
analysis.
According to the revised National Cholesterol Education
Program-Adult Treatment Panel III criteria, BMI was calcu-
lated by dividing the body weight (in kilograms) by the
square of the patient’s height (in meters), and obesity was
defined as BMI  25 kg/m2 [10,11]. The upper limits of WC
were 90 cm for men and 80 cm for women. BP was
measured after the examinees had been seated for > 5
minutes. Systolic BP (SBP) and diastolic BP (DBP) were
recorded as the means of three consecutive readings with a
difference in the SBP of < 10 mmHg. The upper limits of SBP
and DBP were 130 mmHg and 85 mmHg, respectively.
This study complied with the standards of the Declara-
tion of Helsinki and current ethical guidelines. It was
approved by the Institutional Review Board of Taipei Vet-
erans General Hospital (No. 2011-08-010IC).
Biochemical and serologic markers
Venous blood samples were collected after overnight fast-
ing. Serum biochemical tests were measured using Roche/
Hitachi Modular Analytics Systems (Roche Diagnostics
GmbH, Mannheim, Germany). The reference limits of these
tests were as follows: alanine transaminase (ALT) level,
40 IU/L; total cholesterol level, 200 mg/dL; high-density
lipoprotein-cholesterol (HDL-C) level, 40 mg/dL in men and
50 mg/dL in women; low-density lipoprotein-cholesterol
level, 130 mg/dL; triglyceride (TG) level, 150 mg/dL;
fasting glucose level, 100 mg/dL; and 2-hour postload
plasma glucose level, 150 mg/dL.
Endoscopic findings
Eleven experienced endoscopists performed the EGD pro-
cedures and recorded the findings on a digital file system.
EE was diagnosed according to the Los Angles criteria by
two senior endoscopists (Y.-J.W. and J.-C.L., both had
performed more than 5000 EGD procedures) [12]. If the
diagnosis for the same patient was inconsistent between
these two doctors, the digital file was reviewed again to
reach a consensus.
Statistical analysis
To establish and validate a risk scoring system to predict EE,
we divided our study cohort into model derivation (training)
Figure 2 Incidence of erosive esophagitis stratified by age
and time (every 3 years).
Risk score for erosive esophagitis 97and validation sets in a 2:1 ratio. Therefore, we selected
22,892 patients who underwent physical check-ups in the
initial two-thirds of the study period (from October 2002 to
December 2006) as the training set to generate the risk
scoring system for EE, and the remaining 11,454 patients
(from January 2007 to August 2009) as the validation set
(Figure 1).
In the training set, Chi-square analysis was used to
compare categorical variables, and the Student t test was
used to compare continuous variables. Variables with sta-
tistical significance (p < 0.05) or proximate to it (p < 0.1) in
univariate analysis were included in multivariate analysis
using a logistic regression model with the forward stepwise
selection procedure. Subsequently, the independent risk
factors were scored and weighted by b coefficient, and the
risk scoring system for EE was established. Low-, moderate-
, and high-risk groups for EE were stratified according to the
risk scores. We then validated this scoring system in the
validation set and all the enrollees for its discriminative
ability to predict EE among different risk groups.
A two-tailed p < 0.05 was considered statistically sig-
nificant. All statistical analyses were performed using SPSS
17.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
Baseline clinical characteristics and prevalence of
EE
A total of 34,346 patients who underwent health check-ups
were enrolled. EE was identified in 4044 (11.78%) patients
by EGD (EE group), and the remainder were defined as the
normal group. The incidence of EE, stratified by age and
time (per 3 years), had an increasing tendency (Figure 2).Figure 1 Study flow chart. EES Z erosive esophagitis score.Patients in the EE group were significantly older than
those in the normal group (p < 0.001; Table 1). There was
male predominance in both groups; however, the male-to-
female ratio was higher in the EE group (81.2% vs. 50.8%,
p < 0.001). BMI, WC, SBP, and DBP were significantly higher
in the EE group. Lower HDL-C, higher TG, and low-density
lipoprotein-cholesterol were also found in the EE group.
Patients in the EE group also had higher fasting glucose and
ALT levels than those in the normal group (Table 1).Factors associated with EE in the training set
In the training set, univariate analysis showed that older
age, male gender, higher BMI, WC, SBP, DBP, fasting
glucose, ALT, TG, and lower HDL-C were significantly
associated with EE (Table 2).
In multivariate analysis, older age was not only an in-
dependent risk factor for EE, but also associated with a
tendency of increased risk. Male gender, BMI, WC, HDL-C,
and TG were independent risk factors for EE (Table 3).Establishing a risk score for predicting EE in the
training set and validation of the EE score
According to the b coefficient values in Table 3, each in-
dependent risk factor was weighted by different scores and
the risk scoring system for predicting EE was established
(Table 4). The total score ranged from 0 to 10. Low-,
moderate-, and high-risk groups were defined by scores of
0e3, 4e6, and 7e10, respectively.
In the validation set, the prevalence rates of EE in the
low-, moderate-, and high-risk groups were 5.15%, 15.76%,
and 26.11%, respectively (p < 0.001). In all the enrollees
(training and validation sets), the prevalence rates of EE in
the low-, moderate-, and high-risk groups were 4.26%,
12.31%, and 21.3%, respectively (p < 0.001). This scoring
system showed good discriminability for EE prediction by
logistic regression (Figure 3).
Table 1 Baseline characteristics of the study population.
Mean  SD or n (%) Hazard ratio (95% CI) p
Normal group (n Z 30,302) EE group (n Z 4044)
Age (y) 51.8  13.1 54.1  13.0 1.014 (1.011e1.016) <0.0001
Male, n (%) 15401 (50.8) 3285 (81.2) 1.014 (1.011e1.016) <0.0001
BMI (kg/m2) 23.6  3.6 25.1  3.4 1.114 (1.104e1.124) <0.0001
WC (cm) 83.1  10.2 88.4  9.4 1.051 (1.047e1.054) <0.0001
Systolic BP (mmHg) 123.7  18.7 127.3  17.9 1.010 (1.008e1.012) <0.0001
Diastolic BP (mmHg) 77.2  13.6 79.8  19.1 1.012 (1.010e1.015) <0.0001
Fasting glucose (mg/dL) 95.1  24.4 98.6  27.4 1.005 (1.004e1.006) <0.0001
Cholesterol (mg/dL) 198.3  37.2 198.5  36.4 1.000 (0.999e1.001) 0.7577
HDL cholesterol (mg/dL) 54.2  15.2 49.3  13.5 0.976 (0.974e0.978) <0.0001
LDL cholesterol (mg/dL) 124.5  33.0 126.2  32.3 1.002 (1.001e1.002) 0.0028
Triglycerides (mg/dL) 125.5  85.1 152.2  100.2 1.003 (1.002e1.003) <0.0001
ALT (U/L) 28.0  25.4 33.7  39.2 1.006 (1.005e1.007) <0.0001
ALT Z alanine transaminase; BMI Z body mass index; BP Z blood pressure; CI Z confidence interval; EE Z erosive esophagitis;
HDL Z high-density lipoprotein; LDL Z low-density lipoprotein; SD Z standard deviation; WC Z waist circumference.
Table 2 Univariate analysis of risk factors associated with erosive esophagitis in the training set.
Mean  SD or n (%) Hazard ratio (95% CI) p
Normal (n Z 20,523) Erosive esophagitis (n Z 2369)
Age (y) 52.1  13.1 54.7  13.2 1.015 (1.012e1.018) <0.0001
Male, n (%) 10691 (52.1) 1945 (82.1) 4.219 (3.785e4.702) <0.0001
BMI (kg/m2) 23.7  3.5 25.0  3.2 1.109 (1.096e1.122) <0.0001
WC (cm) 83.4  10.1 88.4  9.1 1.050 (1.045e1.054) <0.0001
Systolic BP (mmHg) 125.0  18.7 128.1  18.0 1.009 (1.006e1.011) <0.0001
Diastolic BP (mmHg) 77.9  13.7 79.8  11.6 1.009 (1.006e1.013) <0.0001
Fasting glucose (mg/dL) 96.4  25.0 100.3  29.3 1.005 (1.004e1.006) <0.0001
Cholesterol (mg/dL) 199.2  37.2 200.1  36.6 1.001 (1.000e1.002) 0.2656
HDL cholesterol (mg/dL) 54.8  14.9 50.4  12.9 0.978 (0.975e0.981) <0.0001
LDL cholesterol (mg/dL) 124.6  32.9 126.5  32.6 1.002 (1.000e1.003) 0.0071
Triglycerides (mg/dL) 124.8  79.5 148.6  92.8 1.003 (1.002e1.003) <0.0001
ALT (U/L) 27.6  24.2 32.5  40.0 1.005 (1.004e1.006) <0.0001
ALTZ alanine transaminase; BMIZ body mass index; BPZ blood pressure; CIZ confidence interval; HDLZ high-density lipoprotein;
LDL Z low-density lipoprotein; SD Z standard deviation; WC Z waist circumference.
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Although previous studies have evaluated and established
the risk factors for EE, this study is the first large-scale
study using a health check-up population to establish aTable 3 Multivariate analysis of risk factors associated with er
Parameter B SE
Age 40e60/<40 (y) 0.148 0.069
Age 60/<40 (y) 0.330 0.079
Sex (male/female) 1.386 0.059
BMI 0.215 0.057
WC 0.338 0.056
HDL cholesterol 0.131 0.056
TG 0.184 0.051
BZ b coefficient; BMIZ body mass index; CIZ confidence interval; H
error; TG Z triglyceride; WC Z waist circumference.simple noninvasive scoring system, weighted by the risk
factors of age, gender, BMI, WC, TG, and HDL-C, to effec-
tively predict the occurrence of EE and stratify its inci-
dence. Initially, two-thirds of the participants were
enrolled as the training set to identify the independent riskosive esophagitis in the training set.
HR 95.0% CI for HR p
1.159 1.013 1.327 0.032
1.391 1.191 1.625 <0.001
4.000 3.560 4.494 <0.001
1.240 1.109 1.387 <0.001
1.402 1.256 1.565 <0.001
0.877 0.786 0.980 0.020
1.202 1.088 1.327 <0.001
DLZ high-density lipoprotein; HRZ hazard ratio; SEZ standard
Table 4 Risk scores for predicting erosive esophagitis in
the training set.a
Parameter 0 1 2 3
Age (y) <40 40e60 >60
Sex Female d d Male
BMI (kg/m2) <25 25 d d
WCb Normal d Abnormal d
HDL cholesterolc Normal Abnormal d d
TGd Normal Abnormal d d
BMI Z body mass index; HDL Z high-density lipoprotein;
TG Z triglyceride; WC Z waist circumference; d Z not
applicable.
a Total score range: 0e10; 0e3: low-risk group; 4e6:
moderate-risk group; 7e10: high-risk group.
b Normal WC: Male < 90 cm; female < 80 cm; abnormal
means: male  90 cm, female  80 cm.
c Normal HDL: male > 40 mg/dL; female > 50 mg/dL;
abnormal means: male  40 mg/dL, female  50 mg/dL.
d Normal TG: < 150 mg/dL; abnormal means TG  150 mg/dL.
Risk score for erosive esophagitis 99factors for EE after multivariate regression analysis. These
independent risk factors, including increasing age, male
gender, higher BMI, WC, TG, and lower HDL-C, were then
weighted according to the b coefficient in the multivariate
analysis and used in the noninvasive scoring system. The
remaining one-third of the enrollees were used to validate
and test the discriminability of the scoring system.
The increasing incidence of endoscopic EE in our study
coincides with other physical check-up studies in Taiwan,
which have revealed an increasing incidence of EE in the
past 10 years [13,14]. Our findings are also consistent with
other data from Asia, including China, Japan, Singapore,
Korea, as well as from Europe and America [1,8,9,15].
The impact of aging on the incidence of EE is unclear
[2,9,16]. No relationship between increasing age and GERD
symptoms was found in the Olmsted County study [17,18].
However, an increasing number of recent studies haveFigure 3 Incidence of erosive esophagitis stratified by risk
score. By logistic regression p < 0.001. The erosive esophagitis
score could discriminate between different risk groups in all EE
patients (p < 0.001).suggested that increasing age may be correlated with the
incidence of EE [9,16,19,20]. de Vries et al [21] proposed
that increasing age was correlated with decreased intra-
esophageal pressure and increased gastroesophageal pres-
sure gradient, which can contribute to the development of
hiatus hernia. In this study, we also found a good correla-
tion between the age and the incidence of hiatus hernia
(data not shown), and a good correlation between the
incidence of hiatus hernia and EE, which is consistent with
the finding of previous studies [8,13,22]. However, the aim
of this study was to establish a simple noninvasive method
to predict the occurrence of EE prior to the application of
EGD; thus, hiatus hernia was not included in the analysis.
The association between GERD and sex is also under
debate [2,8,9,16,17,23]. In Japan, GERD occurs predomi-
nantly in females [9]. The explanation for this may be
multifactorial, including a longer life span and higher inci-
dence of hiatus hernia in females in Japan [9,24]. Although
several studies have concluded that there is no significant
association between gender and GERD [2,17], recent
studies have found male gender to be an independent
factor for EE [8,16,23]. The mechanisms may be partly
explained by insulin resistance, which is more prominent in
males than in females [16].
There is a strong positive correlation between BMI and
endoscopic evidence of EE [25] and long-term complica-
tions of GERD, such as Barrett’s esophagus and esophageal
adenocarcinoma [26,27]. Therefore, previous studies have
proposed that the increasing trend of GERD in recent de-
cades may partly be explained by increasing BMI [6,7]. The
mechanism and associations between higher BMI and
increasing EE may largely be explained by increased intra-
gastric and intra-abdominal pressure due to external
compression of the surrounding adipose tissue in obesity,
resultant frequent relaxation of the lower esophageal
sphincter, and hence, the development of mucosal injury in
the esophagus [28,29]. In addition, an abdominal belt study
reproduced the manometric characteristics linking BMI with
reflux [7] and was consistent with the association between
WC and acid reflux [28]. Although both BMI > 25 kg/m2 and
WC were independent risk factors for EE in the present
study, WC was a more dominant predictor than BMI.
Biochemical abnormalities of metabolic syndrome com-
ponents, including elevated TG and lower HDL-C, are
associated with an increased prevalence of both EE and
GERD symptoms [4,15,16]. In addition, metabolic syndrome
is associated with accelerated progression to or attenuated
regression from an erosive status [23]. In our study, higher
TG and low HDL-C were both independent risk factors for
EE. However, the mechanism between abnormal lipid pro-
files and EE was unclear and remains to be clarified.
There are some limitations to this study. First, it was a
retrospective study and lacked qualified questionnaires to
identify the history and symptoms of GERD. Second, factors
such as clinical symptoms and smoking history would be
helpful in further stratifying the patients and in the iden-
tification of the high-risk group [23]. In addition, the
medication history, such as treatment with antacids, H2-
blockers, and proton pump inhibitors, may also poten-
tially affect the results of endoscopic findings in patients
with EE [23]. Third, although the study cohort was based on
a health check-up population, the enrollees cannot
100 H.-H. Hung et al.completely represent the normal population. In addition,
this was a single-center study and may not reflect the whole
picture of GERD in Taiwan. Application of the risk scoring
system to a community-based population may be needed to
validate its good discriminability for EE prediction.
In conclusion, older age, male gender, higher BMI, WC,
TG, and lower HDL-C levels were important and indepen-
dent predictors of EE. This simple noninvasive risk scoring
system, weighting by these factors, effectively predicted
EE and stratified its incidence.Conflicts of interest
All authors declare no conflicts of interest.References
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